# Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

> **NCT02587884** · PHASE1 · UNKNOWN · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT02587884
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587884, "Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02587884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*